Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AngioInsight

Explore full profile

Enables cardiologists to realize the full value of anatomical and physiological diagnostics to augment clinical decisions, improve patient outcomes and reduce cost for the treatment of coronary artery…

Minnetonka, United StatesFounded 2018Health Tech & Medtech
Valuation $100–250M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for AngioInsight and the history behind them.

About AngioInsight

AngioInsight leverages artificial intelligence and computational modeling to transform the care of coronary artery disease. The company provides cardiologists with advanced tools to quantify stenosis severity and non-invasively determine Fractional Flow Reserve (FFR) within the cardiac catheterization lab. This enables more accurate and timely clinical decisions, ultimately improving patient outcomes and reducing treatment costs. AngioInsight primarily serves cardiologists and healthcare institutions focused on coronary artery disease, operating within the medical technology and healthcare sectors. The business model revolves around offering its diagnostic solutions as a service, generating revenue through subscriptions and usage fees. By integrating cutting-edge AI and computational techniques, AngioInsight aims to set a new standard in cardiac care.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Minnetonka, United States
Employees
19
Open positions
None listed
Dealroom signal
43.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Medical Imaging, Hard Tech
Technology
Artificial Intelligence
Business model
Manufacturing
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2025 $25M $100M Undisclosed ↗
SEED✓Equity / VC Apr 2025 — — Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

AngioInsight website traffic

Latest recorded traffic for AngioInsight is 1.4K monthly website visits, up 66.7% over the last three months. AngioInsight's team grew 5.6% over the past year.

Latest monthly visits1.4K 3-month web change+66.7% 1-year team growth+5.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Segtnan AISegtnan's mission is to combat the global burden of neurological disorders through cutting-edge AI technology Odense, Denmark Operational 4 $162K —
Vision Surgery AI Inc.Artificial Intelligence and Computer Vision applied to Surgery in order to reduce Risk of Failure and reduce the costs San Francisco, United States Operational
cureVisionAI-powered optical system for chronic wound analysis Munich, Germany Operational
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning Oxford, United Kingdom Operational
AI4MEDIMAGINGAI4MedImaging developed an AI-based software that performs a fully automatic segmentation of both ventricles and an automatic identification of cardiac patients with normal wall motion Braga, Portugal Operational
AILISCombines dynamic parametric imaging, artificial intelligence and telemedicine to immediately detect symptoms of breast cancer Krakow, Poland Operational
Augere MedicalA startup with a dedicated team of medical doctors, computer scientists and business developers, working to bring cutting-edge AI to medical devices Oslo, Norway Operational
EchoNousSpecializes in the fields of medical devices, ultrasound, POCUS, machine learning, deep learning, and artificial intelligence Redmond, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Other known investors2 additional known investors

  • Accelerate Blue Fund
  • Avestria Ventures
Employees 19 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States87.5%
🇲🇰 North Macedonia6.3%
🇩🇪 Germany6.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AngioInsight on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AngioInsight’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.